ultragenyx pharmaceutical in
Eric W. Linsley CPA
Board Observer, Ultragenyx Pharmaceutical Inc.
|Age||Total Calculated Compensation||This person is connected to 178 board members in 8 different organizations across 15 different industries.|
See Board Relationships
Mr. Eric W. Linsley, CPA, MBA, is a Managing Partner at Pappas Ventures. Prior to joining the firm in 2000, he served as the Chief Financial Officer and Vice President of TriPath Imaging Inc. Mr. Linsley played a key role in the three-way merger between AutoCyte, NeoPath and Neuromedical Systems that created TriPath. Prior to the merger, he served as the Chief Financial Officer and Vice President of Operations at AutoCyte, where Mr. Linsley led it in a successful public ...
60 Leveroni CourtPhone: 415-483-8800
Novato, California 94949
Board Members Memberships*
Chairperson and Member of Executive Committee
Former Director and Member of Compensation Committee
Director, Chairman of Audit Committee and Member of Compensation, Nomination and Governance Committee
New York University
University of Pennsylvania - The Wharton School
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Peer M. Schatz||Chairman of Management Board, Chief Executive Officer and Managing Director|
|Marc D. Grodman M.D.||Founder, Chairman, Chief Executive Officer, President and Managing Director|
Bio-Reference Laboratories Inc.
|Paul R. Sohmer M.D.||Chief Executive Officer, President and Director|
BG Medicine, Inc.
|Kimberly J. Popovits||Chairman of the Board, Chief Executive Officer, President and Member of Non-Management Stock Option Committee|
Genomic Health Inc.
|Jan Groen Ph.D.||Chief Executive Officer and Executive Director|
|€470.7K||Compensation as of Fiscal Year 2013.|